These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Peritoneal equilibrium test with hypertonic exchange: practical application in a peritoneal dialysis program]. Ortiz A; Marrón B; Berlanga JR; Reyero A; Gazapo R Nefrologia; 2001; 21(4):362-9. PubMed ID: 11816512 [TBL] [Abstract][Full Text] [Related]
3. The effect of oxidative stress inhibition with trimetazidine on the peritoneal alterations induced by hypertonic peritoneal dialysis solution. Günal AI; Celiker H; Ustundag B; Akpolat N; Dogukan A; Akcicek F J Nephrol; 2003; 16(2):225-30. PubMed ID: 12768069 [TBL] [Abstract][Full Text] [Related]
4. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability. Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115 [TBL] [Abstract][Full Text] [Related]
5. Changes in peritoneal mesothelial cells phenotype after chronic exposure to glucose or N-acetylglucosamine. Ciszewicz M; Wu G; Tam P; Polubinska A; Breborowicz A Transl Res; 2007 Dec; 150(6):337-42. PubMed ID: 18022595 [TBL] [Abstract][Full Text] [Related]
6. Comparison of peritoneal equilibration test with 2.27% and 3.86% glucose dialysis solution. Cara M; Virga G; Mastrosimone S; Girotto A; Rossi V; D'Angelo A; Bonfante L J Nephrol; 2005; 18(1):67-71. PubMed ID: 15772925 [TBL] [Abstract][Full Text] [Related]
7. By reducing TGF beta 1, octreotide lessens the peritoneal derangements induced by a high glucose solution. Günal AI; Duman S; Sen S; Unsal A; Terzioğlu E; Akçiçek F; Basci A J Nephrol; 2001; 14(3):184-9. PubMed ID: 11439742 [TBL] [Abstract][Full Text] [Related]
9. The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products. Boulanger E; Wautier MP; Gane P; Mariette C; Devuyst O; Wautier JL Nephrol Dial Transplant; 2004 Sep; 19(9):2208-16. PubMed ID: 15213320 [TBL] [Abstract][Full Text] [Related]
10. Time to reconsider saline as the ideal rinsing solution during abdominal surgery. Połubinska A; Winckiewicz M; Staniszewski R; Breborowicz A; Oreopoulos DG Am J Surg; 2006 Sep; 192(3):281-5. PubMed ID: 16920418 [TBL] [Abstract][Full Text] [Related]
11. Preservation of peritoneal morphology and function by pentoxifylline in a rat model of peritoneal dialysis: molecular studies. Hung KY; Huang JW; Chiang CK; Tsai TJ Nephrol Dial Transplant; 2008 Dec; 23(12):3831-40. PubMed ID: 18614818 [TBL] [Abstract][Full Text] [Related]
12. Altered cellular biosynthesis in human peritoneal mesothelial cells exposed to dialysis solutions. Bird SD; Walker RJ Res Commun Mol Pathol Pharmacol; 1996 Mar; 91(3):319-28. PubMed ID: 8829771 [TBL] [Abstract][Full Text] [Related]
13. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options]. Gallar P; Ortega O; Gutiérrez M; Muñoz M; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261 [TBL] [Abstract][Full Text] [Related]
14. A detailed analysis of sodium removal by peritoneal dialysis: comparison with predictions from the three-pore model of membrane function. Aanen MC; Venturoli D; Davies SJ Nephrol Dial Transplant; 2005 Jun; 20(6):1192-200. PubMed ID: 15827048 [TBL] [Abstract][Full Text] [Related]
15. Increased dialysate levels of phospholipids containing unsaturated fatty acid are associated with increased peritoneal transport rate. Zhe XW; Gao F; Nie HG; Tian XK; Chen W; Liu HW; Lindholm B; Axelsson J; Wang T Am J Nephrol; 2008; 28(6):1007-13. PubMed ID: 18648191 [TBL] [Abstract][Full Text] [Related]
16. [Influence of new dialysis solutions on clinical results in patients treated with peritoneal dialysis]. Haag-Weber M Wien Klin Wochenschr; 2005; 117 Suppl 6():89-97. PubMed ID: 16437339 [TBL] [Abstract][Full Text] [Related]
17. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study. Fusshoeller A; Plail M; Grabensee B; Plum J Nephrol Dial Transplant; 2004 Aug; 19(8):2101-6. PubMed ID: 15213322 [TBL] [Abstract][Full Text] [Related]
19. Effects of anaesthesia on fluid and solute transport in a C57BL6 mouse model of peritoneal dialysis. Shin SK; Kamerath CD; Gilson JF; Leypoldt JK Nephrol Dial Transplant; 2006 Oct; 21(10):2874-80. PubMed ID: 16877489 [TBL] [Abstract][Full Text] [Related]
20. Another reason to restrict the use of a hypertonic, glucose-based peritoneal dialysis fluid: its impact on peritoneal macrophage function in vivo. de Fijter CW; Verbrugh HA; Peters ED; Oe PL; van der Meulen J; Donker AJ; Verhoef J Adv Perit Dial; 1991; 7():150-3. PubMed ID: 1680413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]